China’s drug regulator has raised the fees to register drugs and medical devices in the world’s second-biggest pharmaceutical market, as a lack of resources and expertise hinders its ability to process a rising number of applications. Read more


Aesica Pharmaceuticals Srl, has launched a QAD integrated serialisation system to comply with change from China’s FDA at its site in Pianezza. The new requirements brought forward by CFDA cut the serialisation implementation deadline to just 3 months Read more